← Back to Search

Mixed Meal Challenge for Cardiovascular Disease

N/A
Waitlist Available
Led By Thomas Ziegler, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, minute 15, minute 30, hour 1, hour 2, hour 4 and hour 6 during study visits 1, 2, and 3 (up to 6 weeks)
Awards & highlights

Study Summary

This study is evaluating how to collect blood samples for future studies.

Eligible Conditions
  • Cardiovascular Disease
  • High Cholesterol

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, minute 15, minute 30, hour 1, hour 2, hour 4 and hour 6 during study visits 1, 2, and 3 (up to 6 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, minute 15, minute 30, hour 1, hour 2, hour 4 and hour 6 during study visits 1, 2, and 3 (up to 6 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Apolipoprotein AI
Change in Apolipoprotein AII
Apolipoproteins
+23 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lipid, Glucose, and Mixed Meal ChallengesExperimental Treatment3 Interventions
Participants will take part in three different meal challenges on three separate days with approximately two weeks in between. The first meal challenge is the lipid challenge, the second meal challenge is the glucose challenge and third meal challenge is the mixed-meal challenge.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mixed Meal Challenge
2021
N/A
~20
Lipid Challenge
2019
N/A
~50
Glucose Challenge
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,562 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,391 Total Patients Enrolled
Thomas Ziegler, MDPrincipal InvestigatorEmory University
1 Previous Clinical Trials
31 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025